63915-53-7

Basic information

• Product Name: 2-{[(E)-ammonio(imino)methyl]sulfanyl}-N-(2-{[(Z)-ammonio(imino)methyl]sulfanyl}ethyl)-N-methylethanaminium trichloride
• CAS NO: 63915-53-7
• Molecular Formula: C₇H₂₀Cl₃N₅S₂
• Molecular Weight: 344.7562
• Mol File: 63915-53-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 375.4°C at 760 mmHg
• Flash Point: 180.9°C
• Vapor Pressure: 7.78E-06mmHg at 25°C
• CAS DataBase Reference: 2-{[(E)-ammonio(imino)methyl]sulfanyl}-N-(2-{[(Z)-ammonio(imino)methyl]sulfanyl}ethyl)-N-methylethanaminium trichloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2-{[(E)-ammonio(imino)methyl]sulfanyl}-N-(2-{[(Z)-ammonio(imino)methyl]sulfanyl}ethyl)-N-methylethanaminium trichloride(63915-53-7)
• EPA Substance Registry System: 2-{[(E)-ammonio(imino)methyl]sulfanyl}-N-(2-{[(Z)-ammonio(imino)methyl]sulfanyl}ethyl)-N-methylethanaminium trichloride(63915-53-7)

Safety Data

• Hazardous Substances Data: 63915-53-7(Hazardous Substances Data)

Usage

Functional groups

ammonio, imino, and sulfanyl

Ethyl and methyl groups

present in the compound
These alkyl groups affect the compound's steric hindrance and solubility.

Three chloride ions

part of the compound
The presence of these ions may influence the compound's reactivity and stability.

Complex structure

long and complicated name
The compound's structure may lead to potential applications in various fields, such as organic synthesis, medicinal chemistry, or materials science.

Specific chemical structure

reflected in the compound's name
The name provides information about the compound's composition and arrangement of atoms, which is essential for understanding its properties and potential uses.

Need for further research

to fully understand properties and potential uses
Due to the compound's complexity, additional studies are necessary to explore its properties, reactivity, and potential applications in various fields.

Upstream product

• 105-59-9 N-Methyldiethanolamine 
• 54060-15-0 2-[2-hydroxyethyl(methyl)amino]ethanol hydrochloride 
• 55-86-7 mechlorethamine hydrochloride 
• 17356-08-0 thiourea 

Relevant articles and documents

Molecular Routes to Two-Dimensional Metal Dichalcogenides MX2 (M = Mo, W; X = S, Se)

New synthetic access to two-dimensional transition metal dichalcogenides (TMDCs) is highly desired to exploit their extraordinary semiconducting and optoelectronic properties for practical applications. We introduce here an entirely novel class of molecular precursors, [MIV(XEtN(Me)EtX)2] (MIV = MoIV, WIV, X = S, Se), enabling chemical vapor deposition of TMDC thin films. Molybdenum and tungsten complexes of dianionic tridentate pincer-type ligands (HXEt)2NR (R = methyl, tert-butyl, phenyl) produced air-stable monomeric dichalcogenide complexes, [W(SEtN(Me)EtS)2] and [Mo(SEtN(Me)EtS)2], displaying W and Mo centers in an octahedral environment of 4 S and 2 N donor atoms. Owing to their remarkable volatility and clean thermal decomposition, both Mo and W complexes, when used in the chemical vapor deposition (CVD) process, produced crystalline MoS2 and WS2 thin films. X-ray diffraction analysis and atomic-scale imaging confirmed the phase purity and 2D structural characteristics of MoS2 and WS2 films. The new set of ligands presented in this work open ups convenient access to a scalable and precursor-based synthesis of 2D transition metal dichalcogenides.

'3+1' Mixed-ligand oxotechnetium(V) complexes with affinity for melanoma: Synthesis and evaluation in vitro and in vivo

'3+1' Mixed-ligand [99mTc]oxotechnetium complexes with affinity for melanoma were synthesized in a one-pot reaction. Complexation of technetium-99m with a mixture of N-R(3- azapentane-1,5-dithiol) [R = Me, Pr, Bn, Et2N(CH2)2] and N-(2- dialkylamino)ethanethiol [alkyl = X = Et, Bu, morpholinyl] using Sn2+ as the reducing agent resulted in the formation of '3+1' mixed-ligand technetium-99m complexes [TcO(SN(R)S)(SNX2)] in high radiochemical yield (60-98%). In vitro uptake studies in B16 murine melanoma cells indicated a moderate tumor-cell accumulation (40%) of compound 1 [R = Me, X = Et] and a higher accumulation (69%) of compound 2 [R = Me, X = Bu] after a 60-min incubation. In vivo evaluation of compounds 1-6 in the C57B16/B16 mouse melanoma model demonstrated tumor localization. Compound 2 displayed the highest accumulation with up to 5% ID/g at 60 min after injection. In vivo, 2 also showed a low blood-pool activity and high melanoma/spleen (4.3) and melanoma/lung (1.9) ratios at 1 h. These results suggest that small technetium-99m complexes could be useful as potential melanoma-imaging agents.